Phone
ClinicalTrials.gov URL
Acknowledgement
1 business day
Servier
EA Therapies for Single Patient
Vorasidenib - The vorasidenib EAP is designed to provide access to vorasidenib for patients with IDH1- or IDH2-mutated glioma who are not eligible for other vorasidenib clinical trials, and who in the opinion of the treating oncologist would potentially benefit from treatment from vorasidenib.
EA Policies for Single Patient
Single-Patient Expanded Access Policies and Criteria -. Physicians seeking general information may contact Servier by emailing expandedaccess@servier.com .
EA Policies for Disease / Category